About

Mantle cell lymphoma is an aggressive form of non-Hodgkin's lymphoma that originates in the lymph nodes and often resists standard treatments. Tecartus is a CAR T-cell therapy that genetically reprograms a patient's own immune cells to recognize and attack lymphoma cells bearing a specific marker. This targeted approach may offer a new option for patients whose cancer has returned or stopped responding to other therapies.